Research and publications

• Acute liver failure and ICU management

  Olivo, Raquel, James V. Guarrera, and Nikolaos T. Pyrsopoulos. "Liver transplantation for acute liver failure." Clinics in liver disease 22.2 (2018): 409-417. https://pubmed.ncbi.nlm.nih.gov/29605075/
  
  Ramzan, Moazma, et al. "Comparison of CLIF-C ACLF score and MELD score in predicting ICU mortality in patients with acute-on-chronic liver failure." Cureus 12.2 (2020). https://pubmed.ncbi.nlm.nih.gov/32226688/
  
  Zaccherini, Giacomo, Emmanuel Weiss, and Richard Moreau. "Acute-on-chronic liver failure: Definitions, pathophysiology and principles of treatment." JHEP Reports 3.1 (2021): 100176. https://pubmed.ncbi.nlm.nih.gov/33205036/

  AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
  https://aasldpubs.onlinelibrary.wiley.com/doi/epdf/10.1002/hep.32689

• Alcohol associated liver disease

  Thursz, Mark R., et al. "Prednisolone or pentoxifylline for alcoholic hepatitis." New England Journal of Medicine 372.17 (2015): 1619-1628. https://www.nejm.org/doi/full/10.1056/NEJMoa1412278
  
  Marot, Astrid, Christophe Moreno, and Pierre Deltenre. "Liver transplant for alcoholic hepatitis: a current clinical overview." Expert review of gastroenterology & hepatology 14.7 (2020): 591-600. https://pubmed.ncbi.nlm.nih.gov/32511039/

• Basic immunology

  Kumbala, Damodar, and Rubin Zhang. "Essential concept of transplant immunology for clinical practice." World journal of transplantation 3.4 (2013): 113-118. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3879520/

• Cholestatic and autoimmune liver disease

  Mack, Cara L., et al. "Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases." Hepatology 72.2 (2020): 671-722. https://aasldpubs.onlinelibrary.wiley.com/doi/full/10.1002/hep.23584
  
  Lindor, Keith D., et al. "Primary biliary cholangitis: 2018 practice guidance from the American Association for the Study of Liver Diseases." Hepatology 69.1 (2019): 394-419. https://www.aasld.org/sites/default/files/2022-04/PracticeGuidelines-PBC-November2018_1.pdf
  
  Chapman, Roger, et al. "Diagnosis and management of primary sclerosing cholangitis." Hepatology (Baltimore, Md.)51.2 (2010): 660-678. https://europepmc.org/article/med/20101749
  
  Alam, Seema, and Bikrant Bihari Lal. "Recent updates on progressive familial intrahepatic cholestasis types 1, 2 and 3: Outcome and therapeutic strategies." World Journal of Hepatology 14.1 (2022): 98. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790387/

• Liver path and anatomy

  Krishna, Murli. "Microscopic anatomy of the liver." Clinical liver disease 2.Suppl 1 (2013): S4. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448667/
  
  Sibulesky, Lena. "Normal liver anatomy." Clinical liver disease 2.Suppl 1 (2013): S1. https://www.ncbi.nlm.nih.gov/pmc/articles/pmc6448666/
  
  Duke pathology slides
  https://pathology.oit.duke.edu/siteParts/avaps/06.15.1_Liver_Pathology_Final.pdf

• Liver transplant

  Selection and evaluation

  Levitsky, J., et al. "The American Society of Transplantation Consensus Conference on the use of hepatitis C viremic donors in solid organ transplantation." (2017): 2790-2802. https://onlinelibrary.wiley.com/doi/abs/10.1111/ajt.14381
  
  Lai, Jennifer C., et al. "Development of a novel frailty index to predict mortality in patients with end‐stage liver disease." Hepatology 66.2 (2017): 564-574. https://aasldpubs.onlinelibrary.wiley.com/doi/abs/10.1002/hep.29219
  
  Miller, Charles M., et al. "The international liver transplantation society living donor liver transplant recipient guideline." Transplantation 101.5 (2017): 938. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642345/
  

  Surgical approach

  Makowka, Leonard, et al. "Surgical technique of orthotopic liver transplantation." Gastroenterology Clinics of North America 17.1 (1988): 33-51. https://www.sciencedirect.com/science/article/pii/S0889855321003423
  

  Perioperative complications

  Mohanraj, B. Sharmila, Amol S. Rangnekar, and Joseph G. Timpone. "Infections in liver transplantation." Principles and Practice of Transplant Infectious Diseases. Springer, New York, NY, 2019. 41-72. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120017/
  
  Amara, Dominic, et al. "Surgical complications after living and deceased donor liver transplant: The NSQIP transplant experience." Clinical Transplantation (2022): e14610. https://doi.org/10.1111/ctr.14610
  
  Baheti, Akshay D., et al. "Surgical techniques and imaging complications of liver transplant." Radiologic Clinics 54.2 (2016): 199-215. https://pubmed.ncbi.nlm.nih.gov/26896220/
  
  Kochhar, Gursimran, et al. "Biliary complications following liver transplantation." World Journal of Gastroenterology: WJG19.19 (2013): 2841. https://pubmed.ncbi.nlm.nih.gov/23704818/
  
  Chen, Jun, et al. "Surgical and endovascular treatment of hepatic arterial complications following liver transplant." Clinical Transplantation 28.12 (2014): 1305-1312. https://pubmed.ncbi.nlm.nih.gov/25091402/

• Long term management of the transplanted patient

  Hoppmann, Nicholas, and Omar Massoud. "Medical care of liver transplant patients." Expert Review of Gastroenterology & Hepatology 14.10 (2020): 901-918. https://www.tandfonline.com/doi/abs/10.1080/17474124.2020.1797483?casa_token=P6Eh_Kw_d9kAAAAA:SzbahWa5S9jo5FGg-Fz4NQs3R3YpZOO-4Al2YukQ_RKt69NM17_ydiBiIdtSoKh81ELvLdx_Bag
  
  Kelly, Deirdre A., et al. "Long‐term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation." Liver Transplantation 19.8 (2013): 798-8 https://aasldpubs.onlinelibrary.wiley.com/doi/10.1002/lt.23697

• Metabolic and genetic diseases

  Lee, Way S., and Ronald J. Sokol. "Liver disease in mitochondrial disorders." Seminars in liver disease. Vol. 27. No. 03. Copyright© 2007 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA., 2007. https://www.thieme-connect.com/products/ejournals/html/10.1055/s-2007-985071
  
  Kamal, Natasha, Pallavi Surana, and Christopher Koh. "Liver disease in patients with cystic fibrosis." Current opinion in gastroenterology 34.3 (2018): 146. https://www.ncbi.nlm.nih.gov/pmc/articles/pmc7232742/
  
  Rake, Jan, et al. "Guidelines for management of glycogen storage disease type I–European Study on Glycogen Storage Disease Type I (ESGSD I)." European journal of pediatrics 161.1 (2002): S112-S119.
  
  Ross, Katalin M., et al. "Dietary management of the glycogen storage diseases: evolution of treatment and ongoing controversies." Advances in Nutrition 11.2 (2020): 439-446.
  
  Ross, Katalin M., et al. "Safety and efficacy of chronic extended release cornstarch therapy for glycogen storage disease type I." JIMD Reports, Volume 26. Springer, Berlin, Heidelberg, 2015. 85-90.
  
  Strong, Alanna, et al. "Hepatic Manifestations of Urea Cycle Disorders." Clinical Liver Disease 18.4 (2021): 198. https://aasldpubs.onlinelibrary.wiley.com/doi/full/10.1002/cld.1115
  
  
  Palumbo, Chiara Saroli, and Michael L. Schilsky. "Clinical practice guidelines in Wilson disease." Annals of translational medicine 7.Suppl 2 (2019). https://pubmed.ncbi.nlm.nih.gov/31179302/
  
  Bacon, Bruce R., et al. "Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases." Hepatology (Baltimore, Md.) 54.1 (2011): 328. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3149125/
  
  Singal, Ashwani K., et al. "Liver transplantation in the management of porphyria." Hepatology 60.3 (2014): 1082-1089. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4498564/

• NASH (Nonalcoholic Steatohepatitis)

  Chalasani, Naga, et al. "The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases." Hepatology 67.1 (2018): 328-357. https://www.aasld.org/sites/default/files/2022-06/NAFLD%20Guidance%202018.pdf

• Nutrition and cirrhosis

  Jain, Arpan, et al. "L‐ornithine L‐aspartate in acute treatment of severe hepatic encephalopathy: A double‐blind randomized controlled trial." Hepatology 75.5 (2022): 1194-1203. https://doi.org/10.1002/hep.32255
  
  European Association For The Study Of The Liver. "EASL Clinical Practice Guidelines on nutrition in chronic liver disease." Journal of hepatology 70.1 (2019): 172-193. https://pubmed.ncbi.nlm.nih.gov/30144956/

• Outpatient hepatology

  Hilscher, Moira B., et al. "Fontan-associated liver disease." Hepatology 75.5 (2022): 1300-1321. https://aasldpubs.onlinelibrary.wiley.com/doi/epdf/10.1002/hep.32406

  IVIG and serologies

  King, Catherine, Una Sutton-Fitzpatrick, and Julieanne Houlihan. "Transient derangements in Hepatitis B serology in patients post-intravenous immunoglobulin therapy—a case-based review." Irish Journal of Medical Science (1971-) 189.2 (2020): 617-620. https://pubmed.ncbi.nlm.nih.gov/31643027/
  
  Arnold, Donald M., et al. "Misleading hepatitis B test results due to intravenous immunoglobulin administration: implications for a clinical trial of rituximab in immune thrombocytopenia." Transfusion 50.12 (2010): 2577-2581.
  
  Hui, Edwin Pun. "Immunoglobulin therapy and passive transfer of anti-HBc: too often forgotten." The Lancet Haematology 5.10 (2018): e437-e438.
  
  

  Polycystic liver disease

  van Aerts, Rene MM, et al. "Lanreotide reduces liver growth in patients with autosomal dominant polycystic liver and kidney disease." Gastroenterology 157.2 (2019): 481-491.
  
  Gevers, Tom JG, et al. "Effect of lanreotide on polycystic liver and kidneys in autosomal dominant polycystic kidney disease: an observational trial." Liver International 35.5 (2015): 1607-1614.
  
  Neijenhuis, M.K., Gevers, T.J., Nevens, F. et al. Somatostatin analogues improve health-related quality of life in polycystic liver disease: a pooled analysis of two randomised, placebo-controlled trials. Aliment Pharmacol Ther. 2015; 42: 591–598
  
  

  Short telomere syndrome

  Schratz, Kristen E. "Extrahematopoietic manifestations of the short telomere syndromes." Hematology 2014, the American Society of Hematology Education Program Book 2020.1 (2020): 115-122. https://ashpublications.org/hematology/article/2020/1/115/474343/Extrahematopoietic-manifestations-of-the-short
  
  Armanios, Mary, and Elizabeth H. Blackburn. "The telomere syndromes." Nature Reviews Genetics 13.10 (2012): 693-704. https://pubmed.ncbi.nlm.nih.gov/22965356/
  
  Kalra, Avash, and J. P. Norvell. "Cause for confusion: noncirrhotic hyperammonemic encephalopathy." Clinical Liver Disease 15.6 (2020): 223. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326631/

• Portal hypertension

  Bozbas, Serife Savas, and Huseyin Bozbas. "Portopulmonary hypertension in liver transplant candidates." World Journal of Gastroenterology 22.6 (2016): 2024. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726675/
  
  Iwakiri, Yasuko, and Jonel Trebicka. "Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy." JHEP Reports 3.4 (2021): 100316. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318926/
  
  Koch, David G., and Michael B. Fallon. "Hepatopulmonary syndrome." Clinics in liver disease 18.2 (2014): 407-420. https://pubmed.ncbi.nlm.nih.gov/24679503/

• Pregnancy and liver disease

  Russell, Michelle A., and Sabrina D. Craigo. "Cirrhosis and portal hypertension in pregnancy." Seminars in perinatology. Vol. 22. No. 2. WB Saunders, 1998.
  
  Aggarwal, N., et al. "Non-cirrhotic portal hypertension in pregnancy." International journal of gynecology & obstetrics 72.1 (2001): 1-7.
  
  Aggarwal, Neelam, et al. "Pregnancy with portal hypertension." Journal of clinical and experimental hepatology 4.2 (2014): 163-171.
  
  Sarkar, Monika, et al. "Reproductive Health and Liver Disease: Practice Guidance by the American Association for the Study of Liver Diseases." Hepatology (Baltimore, Md.) (2020). https://aasldpubs.onlinelibrary.wiley.com/doi/epdf/10.1002/hep.31559
  
  Goel, Ashish, et al. "Pregnancy-related liver disorders." Journal of Clinical and Experimental Hepatology 4.2 (2014): 151-162. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4116710/

• Statistics

  Krousel-Wood, Marie A., Richard B. Chambers, and Paul Muntner. "Clinicians' guide to statistics for medical practice and research: part I." The Ochsner Journal 6.2 (2006): 68. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121570/

• Transplant Immunology Immune suppression and rejection

  Ascha, Mustafa S., Mona L. Ascha, and Ibrahim A. Hanouneh. "Management of immunosuppressant agents following liver transplantation: less is more." World journal of hepatology 8.3 (2016): 148. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724578/
  
  Charlton, Michael, et al. "International liver transplantation society consensus statement on immunosuppression in liver transplant recipients." Transplantation 102.5 (2018): 727-743. https://journals.lww.com/transplantjournal/Fulltext/2018/05000/International_Liver_Transplantation_Society.13.aspx?casa_token=om4erDyDLawAAAAA:qywBkW1eG20sBVipCyYPW8Ucd6mPqFBzoOtRZ99ftcGzSQHet_4ZzPOBrcfrH6572LIodtULEGDnknBYkLjexw
  
  Demetris, Anthony J., et al. "Banff schema for grading liver allograft rejection: an international consensus document." Hepatology 25.3 (1997): 658-663. https://mayoclinic.pure.elsevier.com/en/publications/banff-schema-for-grading-liver-allograft-rejection-an-internation
  
  Demetris, A. Jake, et al. "2016 Comprehensive update of the Banff Working Group on liver allograft pathology: introduction of antibody‐mediated rejection." (2016): 2816-2835. https://onlinelibrary.wiley.com/doi/abs/10.1111/ajt.13909

• Tumors of the liver

  Assy, Nimer, et al. "Characteristics of common solid liver lesions and recommendations for diagnostic workup." World journal of gastroenterology: WJG 15.26 (2009): 3217. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2710776/
  
  Hackl, Christina, et al. "Liver transplantation for malignancy: current treatment strategies and future perspectives." World Journal of Gastroenterology: WJG 20.18 (2014): 5331. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017048/
  
  Al‐Adra, David P., et al. "Pretransplant solid organ malignancy and organ transplant candidacy: a consensus expert opinion statement." American Journal of Transplantation 21.2 (2021): 460-474. https://onlinelibrary.wiley.com/doi/10.1111/ajt.16318
  
  Rosen, Charles B., Julie K. Heimbach, and Gregory J. Gores. "Liver transplantation for cholangiocarcinoma." Transplant International 23.7 (2010): 692-697. https://onlinelibrary.wiley.com/doi/full/10.1111/j.1432-2277.2010.01108.x
  

• Viral hepatitidies

  Hepatitis C

  Hepatitis C treatment guidelines by AASLD and the IDSA https://www.hcvguidelines.org/
  
  Ghany, Marc G., Timothy R. Morgan, and AASLD‐IDSA hepatitis C guidance panel. "Hepatitis C guidance 2019 update: American Association for the Study of Liver Diseases–Infectious Diseases Society of America recommendations for testing, managing, and treating hepatitis C virus infection." Hepatology 71.2 (2020): 686-721. https://aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31060

  Hepatitis B

  Terrault, Norah A., et al. "Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance." Hepatology 67.4 (2018): 1560-1599. https://aasldpubs.onlinelibrary.wiley.com/doi/abs/10.1002/hep.29800
  
  Spyrou, Elias, Coleman I. Smith, and Marc G. Ghany. "Hepatitis B: Current status of therapy and future therapies." Gastroenterology Clinics 49.2 (2020): 215-238. https://pubmed.ncbi.nlm.nih.gov/32389360/
  
  Ekpanyapong, Sirina, and K. Rajender Reddy. "Hepatitis B virus reactivation: what is the issue, and how should it be managed?." Clinics in Liver Disease 24.3 (2020): 317-333. https://pubmed.ncbi.nlm.nih.gov/32620274/
  
  Huang, Daniel Q., Guan Sen Kew, and Seng Gee Lim. "Controversies in Treating Chronic Hepatitis B virus: The Role of Hepatitis B Virus DNA and Surface Antigen Titer." Clinics in Liver Disease 25.4 (2021): 763-784. https://pubmed.ncbi.nlm.nih.gov/34593152/

  HAV, HDV, HEV

  Abutaleb, Ameer, and Shyam Kottilil. "Hepatitis A: epidemiology, natural history, unusual clinical manifestations, and prevention." Gastroenterology Clinics 49.2 (2020): 191-199. https://pubmed.ncbi.nlm.nih.gov/32389358/
  
  Niro, Grazia A., et al. "Hepatitis delta virus: From infection to new therapeutic strategies." World Journal of Gastroenterology 27.24 (2021): 3530. https://pubmed.ncbi.nlm.nih.gov/34239267/
  
  Hercun, Julian, Christopher Koh, and Theo Heller. "Hepatitis delta: prevalence, natural history, and treatment options." Gastroenterology Clinics 49.2 (2020): 239-252. https://pubmed.ncbi.nlm.nih.gov/32389361/
  
  Aslan, Abdullah Tarık, and Hatice Yasemin Balaban. "Hepatitis E virus: Epidemiology, diagnosis, clinical manifestations, and treatment." World journal of gastroenterology 26.37 (2020): 5543. https://pubmed.ncbi.nlm.nih.gov/33071523/

  Other viral infections

  Jothimani, Dinesh, et al. "COVID-19 and the liver." Journal of hepatology 73.5 (2020): 1231-1240. https://www.journal-of-hepatology.eu/article/S0168-8278(20)30377-9/fulltext
  
  Faruqui, Saamia, et al. "Cholangiopathy after severe COVID-19: clinical features and prognostic implications." Official journal of the American College of Gastroenterology| ACG116.7 (2021): 1414-1425. https://pubmed.ncbi.nlm.nih.gov/33993134/
  
  Spengler, Ulrich, Hans-Peter Fischer, and Wolfgang H. Caselmann. "Liver Disease Associated with Viral Infections." Zakim and Boyer's Hepatology (2012): 629. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152320/